Stevanato Group (NYSE:STVN – Get Rating) released its quarterly earnings results on Thursday. The company reported €0.12 ($0.12) earnings per share for the quarter, hitting the consensus estimate of €0.12 ($0.12), Briefing.com reports. The business had revenue of €234.20 million during the quarter, compared to analysts’ expectations of €228.53 million. Stevanato Group had a return on equity of 16.39% and a net margin of 14.57%. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period last year, the firm posted $0.15 EPS. Stevanato Group updated its FY22 guidance to 0.51-0.53 EPS and its FY 2022 guidance to $0.54-$0.56 EPS.
Stevanato Group Price Performance
STVN stock traded up €0.86 ($0.89) during midday trading on Friday, reaching €18.27 ($18.84). 150,700 shares of the stock were exchanged, compared to its average volume of 327,105. The stock has a market capitalization of $5.40 billion and a PE ratio of 32.63. Stevanato Group has a 52 week low of €13.35 ($13.76) and a 52 week high of €29.18 ($30.08). The company has a debt-to-equity ratio of 0.22, a current ratio of 2.48 and a quick ratio of 2.01. The company has a fifty day moving average price of €15.82 and a 200 day moving average price of €16.67.
Stevanato Group Dividend Announcement
The company also recently disclosed a — dividend, which was paid on Wednesday, July 13th. Investors of record on Tuesday, June 14th were given a dividend of $0.051 per share. The ex-dividend date was Monday, June 13th. This represents a yield of 0.4%.
Institutional Investors Weigh In On Stevanato Group
Analysts Set New Price Targets
Separately, Wells Fargo & Company decreased their price target on Stevanato Group from $21.00 to $19.00 and set an “overweight” rating on the stock in a research note on Monday, April 25th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of €25.21 ($25.99).
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
Featured Stories
- Get a free copy of the StockNews.com research report on Stevanato Group (STVN)
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- BJ’s Wholesale Club Stock Has More Room to Grow
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.